We serve Chemical Name:3-methyl-4-nitro-1,2-thiazol-5-amine CAS:40184-32-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-methyl-4-nitro-1,2-thiazol-5-amine
CAS.NO:40184-32-5
Synonyms:5-amino-3-methyl-4-nitroisothiazole;5-Amino-3-methyl-4-nitroisothiazol (III);5-Isothiazolamine,3-methyl-4-nitro;3-methyl-4-nitro-isothiazol-5-ylamine;3-Methyl-4-nitro-isothiazol-5-ylamin
Molecular Formula:C4H5N3O2S
Molecular Weight:159.16600
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:112.97000
Exact Mass:159.01000
LogP:2.04630
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-amino-3-methyl-4-nitroisothiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Methyl-4-nitro-isothiazol-5-ylamin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-methyl-4-nitro-isothiazol-5-ylamine Use and application,3-Methyl-4-nitro-isothiazol-5-ylamin technical grade,usp/ep/jp grade.
Related News: “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 3-methyl-4-nitro-1,2-thiazol-5-amine manufacturer AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. 3-methyl-4-nitro-1,2-thiazol-5-amine supplier ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. 3-methyl-4-nitro-1,2-thiazol-5-amine vendor “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 3-methyl-4-nitro-1,2-thiazol-5-amine factory “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.”
